Latest News

CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union

Emvolon Raises $22 million Funding Round to Launch its Modular, Waste-to-Fuel Chemical Plants

Central Bancompany, Inc. Reports Third Quarter 2026 Results

MeiraGTx Announces Four Posters at the European Society of Gene and Cell Therapy (ESGCT) 2026 Annual Congress and the Network of Excellence for ALS (NEALS) Annual Meeting

Teva Acquires Worldwide Rights to BXCL501, Further Expanding Innovative Neuroscience Pipeline

Microchip Achieves Key Program Milestones for its PIC64-HPSC Spaceflight Computing Series

WISeSat.Space and Kaynes Space Technology Advance Partnership to Develop Post-Quantum Security for Indian Satellites

Absci to Participate in Upcoming Investor Conferences

Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal

Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results